Trial Profile
A Phase II Study of Irinotecan and Taxotere With Concurrent Radiotherapy as a Preoperative Treatment in Resectable Esophageal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 May 2023
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Irinotecan (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 10 Nov 2006 New trial record.